Although PDE5 mutations are not associated with overall survival in patients with lung cancer, we decided to test the effect of PDE5 inhibition because the PDE5 inhibitor sildenafil is one of the most studied PDE inhibitors across multiple solid tumors [24], broadening the potential impact of this investigation. The gene discussed is PDE5A; the disease is lung carcinoma.